Literature DB >> 2221996

Pancytopenia in a patient given pyrimethamine and sulphamethoxidiazine during pregnancy.

A Pajor1.   

Abstract

This is a report of a pregnant woman who became pancytopenic in the second trimester following pyrimethamine administration. The patient recovered on steroid, antibiotics, transfusion, folic acid and folinic acid therapy, and the pregnancy was uneventful afterwards. The patient was delivered of a healthy term-infant.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2221996     DOI： 10.1007/bf02389547

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN： 0932-0067            Impact factor:   2.344


  9 in total

1.  Agranulocytosis due to dapsone.

Authors:  F C Firkin; A F Mariani
Journal:  Med J Aust       Date:  1977-08-20       Impact factor: 7.738

2.  Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.

Authors:  C Leport; F Raffi; S Matheron; C Katlama; B Regnier; A G Saimot; C Marche; C Vedrenne; J L Vilde
Journal:  Am J Med       Date:  1988-01       Impact factor: 4.965

3.  Erythroderma resembling sézary syndrome after treatment with Fansidar and chloroquine.

Authors:  J A Langtry; J I Harper; R C Staughton; P Barrington
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-26

4.  Accidental overdose of pyrimethamine and sulphadoxine for malaria prophylaxis without adverse effects.

Authors:  A Lindberg; Y Bergqvist; L Rombo
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Maloprim and agranulocytosis.

Authors:  L J Bruce-Chwatt; D B Hutchinson
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

6.  Teratogenicity of pyrimethamine.

Authors:  J P Harpey; Y Darbois; G Lefèbvre
Journal:  Lancet       Date:  1983-08-13       Impact factor: 79.321

7.  Pyrimethamine combinations in pregnancy.

Authors: 
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

8.  Adverse reactions to pyrimethamine/sulfadoxine.

Authors:  J Koch-Weser; C Hodel; R Leimer; S Styk
Journal:  Lancet       Date:  1982-12-25       Impact factor: 79.321

9.  Haematological safety of long-term malarial prophylaxis with dapsone-pyrimethamine.

Authors:  I F Cook; M Y Kish
Journal:  Med J Aust       Date:  1985-08-19       Impact factor: 7.738
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.